Schizophrenia Research
Volume 115, Issue 2 , Pages 104-114 , December 2009

Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study

  • Silvana Galderisi

      Affiliations

    • Department of Psychiatry, University of Naples SUN, Naples, Italy
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University of Naples SUN, Largo Madonna delle Grazie, 80138 Naples, Italy. Tel.: +39 081 5666504; fax: +39 081 5666523.
    • ,
  • Michael Davidson

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • René S. Kahn

      Affiliations

    • Department of Psychiatry, Rudolf Magnus Institute of Neuroscience University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • Armida Mucci

      Affiliations

    • Department of Psychiatry, University of Naples SUN, Naples, Italy
    • ,
  • Han Boter

      Affiliations

    • Department of Psychiatry, Rudolf Magnus Institute of Neuroscience University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • Mihai D. Gheorghe

      Affiliations

    • Department of Psychiatry, Central Military Hospital, Bucharest, Romania
    • ,
  • Janusz K. Rybakowski

      Affiliations

    • Department of Adult Psychiatry, University of Medical Sciences, Poznan, Poland
    • ,
  • Jan Libiger

      Affiliations

    • Department and Clinic of Psychiatry, Charles University Medical School and Faculty Hospital, Hradec Králové, Czech Republic
    • ,
  • Sonia Dollfus

      Affiliations

    • Centre Esquirol, Centre Hospitalier Universitaire, Caen, France
    • ,
  • Juan J. López-Ibor

      Affiliations

    • Institute of Psychiatry and Mental Health, Hospital Clínico San Carlos, Madrid, Spain
    • ,
  • Joseph Peuskens

      Affiliations

    • University Psychiatric Centre, Campus St. Jozef Kortenberg, Katholieke Universiteit Leuven, Leuven, Belgium
    • ,
  • Luchezar G. Hranov

      Affiliations

    • Department and Clinic of Psychiatry, University Hospital of Neurology and Psychiatry St Naum, Sofia, Bulgaria
    • ,
  • Wolfgang W. Fleischhacker

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    • ,
  • EUFEST group

      Affiliations

    • Management group: R S Kahn, WW Fleischhacker, H Boter, C Brugman, H Burger, D E Grobbee, M C Hafkamp, I P M Keet, K Nijssen. Steering Committee: R S Kahn, WW Fleischhacker, H Boter, I P M Keet, C Brugman, M Davidson, S Dollfus, W Gaebel, S Galderisi, M Gheorghe, I Gonen, D E Grobbee, L G Hranov, M Hummer, J Libiger, N Lindefors, JJ López-Ibor, K Nijssen, J Peuskens, A Riecher-Rössler, JK Rybakowski, G Sedvall, M v Wilmsdorff. Office manager: P C Ywema. Julius Centre Study Team: data management—N Boekema, H den Breeijen, M van den Haak, P Huizinga, R Veen; project managers—C Brugman, M C Hafkamp, KM Nijssen; site monitoring—P Berackova, A Blizanowska, C Brugman, M C Hafkamp, T Huizinga, H van Gelderen, M Gordat, S Lorteau, G Makhanlal, H Moqadar. Tangent Data Study Team (co-monitoring Romania): I Gonen, A Mihailescu, R Radici, C Zus. Participating investigators (CC=Country coordinator; SC=site coordinator), centres, and countries: Austria—M Hummer (CC and SC Innsbruck), M Muhlbacher (SC Salzburg), H Widmoser (SC Hall in Tirol); Belgium—J Peuskens (CC), J Hulselmans (SC Antwerpen), C Mertens (SC Gent),E Thijs (SC Kortenberg); Bulgaria—L G Hranov (CC and SC Sofi a),S Georgiev (SC Plovdiv), L Sayan (SC Bourgas); Czech Republic—J Libiger (CC and SC Hradec Kràlové, E Češkovà (SC Brno), D Seifertovà (SC Praha-Bohnice); France: S Dollfus (CC and SC Caen I), G Allio (SC Rouen), B Chabot (SC Caen II), A Navarre Coulaud (SC Dieppe), P Thomas (SC Lille); Germany—W Gaebel (CC), M Krebs (SC Berlin), R Lencer (SC L・eck), K Leopold (SC Berlin), T Wobrock (SC Homburg); Israel—M Davidson (CC), Y Abramovitch (SC Beer-Yaakov), D Amital (SC Ness Ziona), A Caspi (SC Ramat Gan), A Kaplan (SC Beer Sheva), I Treves (SC Shalvata), P Zipris (SC Pardessiya); Italy—S Galderisi (CC), M Casacchia (SC L'Aquila), M Mauri (SC Milano II), A Mucci (SC Naples); Netherlands—H Boter (CC and SC Utrecht), I P M Keet (CC and SC Utrecht); Poland—JK Rybakowski (CC and SC Poznan), M Jarema (SC Warsaw), M Masiak (SC Lublin), J Rabe-Jablonska (SC Lodz); Romania—M Gheorghe (CC), V Burtea (SC Brasov), P Boisteanu (SC Iasi), C Friedman (SC Constanta), M Ienciu (SC Timisoara), A Ionescu (SC Buzau), I Miclutia (SC Cluj), T Mihai (SC Tulcea), D Prelipceanu (SC Bucuresti II), T Udistroiu (SC Craiova), D Vasile (SC Bucuresti I); Spain—JJ López-Ibor (CC), JL Carrasco (SC Madrid); Sweden—N Lindefors (CC and SC Stockholm), G Sedvall (CC), F A Wiesel (SC Uppsala); Switzerland—A Riecher-Rössler (CC), U Gschwandtner (SC Basel).

Received 8 March 2009 ,Revised 17 September 2009 ,Accepted 21 September 2009.

References 

  1. Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr. Res. 1992;6(3):201–208
  2. Addington J, Addington D. Substance abuse and cognitive functioning in schizophrenia. J. Psychiatry Neurosci. 1997;22(2):99–104
  3. Addington J, Brooks BL, Addington D. Cognitive functioning in first episode psychosis: initial presentation. Schizophr. Res. 2003;62(1–2):59–64
  4. Amminger GP, Edwards J, Brewer WJ, Harrigan S, McGorry PD. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr. Res. 2002;54(3):223–230
  5. Ayres AM, Busatto GF, Menezes PR, Schaufelberger MS, Coutinho L, Murray RM, et al. Cognitive deficits in first-episode psychosis: a population-based study in São Paulo. Brazil Schizophr. Res. 2007;90(1–3):338–343
  6. Barnes TR, Leeson VC, Mutsatsa SH, Watt HC, Hutton SB, Joyce EM. Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia. Br. J. Psychiatry. 2008;193(3):203–209
  7. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry. 2000;157(4):549–559
  8. Braw Y, Bloch Y, Mendelovich S, Ratzoni G, Gal G, Harari H, et al. Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients. Schizophr. Bull. 2008;34(3):544–554
  9. Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM, Franco S. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J. Clin. Psychiatry. 1991;52(1):26–30
  10. Costa LD, Vaughan HG, Levita E, Farber N. Purdue Pegboard as a predictor of the presence and laterality of cerebral lesions. J. Consult. Psychol. 1963;27:133–137
  11. Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomised, open-label clinical trial (EUFEST). Am. J. Psychiatry. 2009;166:675–682
  12. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch. Gen. Psychiatry. 2007;64(5):532–542
  13. Fleischhacker WW, Keet IP, Kahn RS EUFEST Steering Committee. The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial. Schizophr. Res. 2005;78(2–3):147–156
  14. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res. 2004;72(1):41–51
  15. Guy W. Clinical Global Impressions (CGI) Scale. In:  Rush AJ,  Pincus HA,  First MB,  Blacker D,  Endicott J,  Keith SJ,  Phillips KA,  Ryan ND,  Smith GR,  Tsuang MT,  Widiger TA,  Zarin DA editor. Handbook of Psychiatric Measures. Washington: American Psychiatric Association; 2000;p. 100–102
  16. Harris AW, Williams L, Gordon E, Bahramali H, Slewa-Younan S. Different psychopathological models and quantified EEG in schizophrenia. Psychol. Med. 1999;29(5):1175–1181
  17. Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia. Schizophr. Res. 2004;68(1):1–9
  18. Ho BC, Alicata D, Ward J, Moser DJ, O'Leary DS, Arndt S, et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am. J. Psychiatry. 2003;160(1):142–148
  19. Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, DeLisi LE. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am. J. Psychiatry. 2000;157(11):1824–1828
  20. Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008;371(9618):1085–1097
  21. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13(2):261–276
  22. Keefe RS. Should cognitive impairment be included in the diagnostic criteria for schizophrenia?. World Psychiatry. 2008;7(1):22–28
  23. Klingberg S, Wittorf A, Wiedemann G. Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions?. Eur. Arch. Psychiatry Clin. Neurosci. 2006;256(8):532–540
  24. Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S. Comparative profile analysis of cognitive function in recent-onset and chronic patients with adolescent-onset schizophrenia. Schizophr. Res. 2007;94(1–3):240–244
  25. Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT. Heterogeneity of schizophrenia: a study of individual neuropsychological profiles. Schizophr. Res. 2004;71(2–3):307–321
  26. Lappin JM, Morgan KD, Morgan C, Dazzan P, Reichenberg A, Zanelli JW, et al. Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophr. Res. 2007;95(1–3):103–110
  27. Leeson VC, Barnes TR, Harrison M, Matheson E, Harrison I, Mutsatsa SH, et al. The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr. Bull. 2008;Aug. 4 Electronic publication ahead of print
  28. Lucas S, Fitzgerald D, Redoblado-Hodge MA, Anderson J, Sanbrook M, Harris A, et al. Neuropsychological correlates of symptom profiles in first episode schizophrenia. Schizophr. Res. 2004;71(2–3):323–330
  29. Marder SR, Fenton W. Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr. Res. 2004;72(1):5–9
  30. Morrens M, Hulstijn W, Matton C, Madani Y, van Bouwel L, Peuskens J, et al. Delineating psychomotor slowing from reduced processing speed in schizophrenia. Cogn. Neuropsychiatry. 2008;13(6):457–471
  31. Morrens M, Hulstijn W, Sabbe B. Psychomotor slowing in schizophrenia. Schizophr. Bull. 2007;33(4):1038–1053
  32. Morrens M, Hulstijn W, Van Hecke J, Peuskens J, Sabbe BG. Sensorimotor and cognitive slowing in schizophrenia as measured by the Symbol Digit Substitution Test. J. Psychiatr. Res. 2006;40(3):200–206
  33. Norman RM, Townsend L, Malla AK. Duration of untreated psychosis and cognitive functioning in first-episode patients. Br. J. Psychiatry. 2001;179:340–345
  34. Oie M, Rund BR, Sundet K, Bryhn G. Auditory laterality and selective attention: normal performance in patients with early-onset schizophrenia. Schizophr. Bull. 1998;24(4):643–652
  35. Pedersen A, Siegmund A, Ohrmann P, Rist F, Rothermundt M, Suslow T, et al. Reduced implicit and explicit sequence learning in first-episode schizophrenia. Neuropsychologia. 2008;46(1):186–195
  36. Pencer A, Addington J. Substance use and cognition in early psychosis. J. Psychiatry Neurosci. 2003;28(1):48–54
  37. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry. 2005;162(10):1785–1804
  38. Perkins DO, Leserman J, Jarskog LF, Graham K, Kazmer J, Lieberman JA. Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophr. Res. 2000;44(1):1–10
  39. Reitan RM, Wolfson D. The Halstead–Reitan neuropsychological test battery: theory and clinical interpretation. second ed.. Tucson: Neuropsychology Press; 1993;
  40. Rey A. L'Examen clinique en psychologie. Paris: Presses Universitaires de France; 1964;
  41. Rund BR, Melle I, Friis S, Larsen TK, Midbøe LJ, Opjordsmoen S, et al. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am. J. Psychiatry. 2004;161(3):466–472
  42. Rund BR, Zeiner P, Sundet K, Oie M, Bryhn G. No vigilance deficit found in either young schizophrenic or ADHD subjects. Scand. J. Psychol. 1998;39(2):101–107
  43. Serper MR, Bergman A, Copersino ML, Chou JC, Richarme D, Cancro R. Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients. Psychiatry Res. 2000;93(1):21–32
  44. Sevy S, Kay SR, Opler LA, van Praag HM. Significance of cocaine history in schizophrenia. J. Nerv. Ment. Dis. 1990;178(10):642–648
  45. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 1998;59(Suppl 20):22–33
  46. Wechsler D. Wechsler Adult Intelligence Scale, revised edn.. San Antonio: Psychological Corporation; 1974;

PII: S0920-9964(09)00441-1

doi: 10.1016/j.schres.2009.09.022

Schizophrenia Research
Volume 115, Issue 2 , Pages 104-114 , December 2009

Article Tools

* Image Usage & Resolution